A heterogeneous patient population refers to a group of cancer patients who have diverse characteristics such as differing ages, genders, genetic backgrounds, stages of disease, and responses to treatment. This diversity can influence the outcomes and effectiveness of cancer therapies, making it a crucial factor in cancer research and clinical trials.
